Tuxarin ER FDA Approval History
FDA Approved: Yes (First approved June 22, 2015)
Brand name: Tuxarin ER
Generic name: chlorpheniramine and codeine
Dosage form: Extended Release Tablets
Company: Spriaso LLC
Treatment for: Cough, Cold Symptoms
Tuxarin ER (codeine and chlorpheniramine) is a long acting narcotic antitussive and antihistamine combination for the treatment of cough and cold symptoms.
Development Timeline for Tuxarin ER
|Jul 1, 2015||ApprovalSpriaso Announces FDA Approval of Long Acting Tuxarin ER (codeine and chlorpheniramine)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.